Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: The ABSORB trial

EuroIntervention

Volumn 7, Issue 9, 2012, Pages 1060-1061

  Dudek, Dariusz ^a   Onuma, Yoshinobu ^b   Ormiston, John A ^c   Thuesen, Leif ^d   Miquel Hebert, Karine ^e   Serruys, Patrick W ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e ABBOTT VASCULAR   (United States)

Author keywords

Bioresorbable scaffold; Coronary artery disease; Long term outcome

Indexed keywords

CLOPIDOGREL; EVEROLIMUS; TISSUE SCAFFOLD;

ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DEVICE SAFETY; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; TREATMENT OUTCOME; TREND STUDY;

BLOOD VESSEL PROSTHESIS; COHORT STUDIES; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MYOCARDIAL INFARCTION; RISK FACTORS; SIROLIMUS; THROMBOSIS; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84856285896     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I9A168     Document Type: Article

References (4)

1. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hebert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910.
2. Onuma Y, Serruys PW, Ormiston JA, Regar E, Webster M, Thuesen L, Dudek D, Veldhof S, Rapoza R. Three-Year Results of Clinical Follow-Up after a Bioresorbable Everolimus-Eluting Scaffold in Patients with De Novo Coronary Artery Disease: the ABSORB Trial. EuroIntervention 2010;6-online publish-ahead-of-print June 2010.
3. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008;371:899-907. (Pubitemid 351384734)
4. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115: 2344-2351. (Pubitemid 46685903)